Next, to relate the CDK4 modification profiles to PD0332991 sensitivity in breast cancer cell lines, we selected 20 previously studied cell lines (Finn et al, 2009; Barretina et al, 2012; Garnett et al, 2012). The gene discussed is CDK4; the disease is breast carcinoma.